A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Gómez-Reino Carnota, Juan Jesús
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/4707
PMID: 22006202
ISSN: 0004-3591
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Data de publicación
2012
Título da revista
ARTHRITIS AND RHEUMATISM
Tipo de contido
Artigo